Previous Close | 979.00 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 0.00 - 0.00 |
52 Week Range | |
Volume | |
Avg. Volume | 3,692,058 |
Market Cap | 8.603B |
Beta (5Y Monthly) | 0.51 |
PE Ratio (TTM) | 40.69 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.30 (3.10%) |
Ex-Dividend Date | Mar 28, 2024 |
1y Target Est | N/A |
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]